Publicaciones en colaboración con investigadores/as de University of Sassari (18)

2023

  1. Long-term outcomes of patients with normal fractional flow reserve and thin-cap fibroatheroma

    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 18, Núm. 13, pp. e1099-e1107

2021

  1. Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired Pneumonia

    Chest, Vol. 159, Núm. 1, pp. 58-72

  2. Correction to: Bacterial etiology of community-acquired pneumonia in immunocompetent hospitalized patients and appropriateness of empirical treatment recommendations: an international point-prevalence study (European Journal of Clinical Microbiology & Infectious Diseases, (2020), 39, 8, (1513-1525), 10.1007/s10096-020-03870-3)

    European Journal of Clinical Microbiology and Infectious Diseases

  3. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  4. Thrombocytosis during Stable State Predicts Mortality in Bronchiectasis

    Annals of the American Thoracic Society, Vol. 18, Núm. 8, pp. 1316

2020

  1. Correction to: Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective (BMC Infectious Diseases, (2018), 18, 1, (677), 10.1186/s12879-018-3565-z)

    BMC Infectious Diseases

2019

  1. An international perspective on hospitalized patients with viral community-acquired pneumonia

    European Journal of Internal Medicine, Vol. 60, pp. 54-70

  2. Prevalence and etiology of community-acquired pneumonia in immunocompromised patients

    Clinical Infectious Diseases, Vol. 68, Núm. 9, pp. 1482-1493

2018

  1. Novel sulfenamides and sulfonamides based on pyridazinone and pyridazine scaffolds as CB1 receptor ligand antagonists

    Bioorganic and Medicinal Chemistry, Vol. 26, Núm. 1, pp. 295-307

2017

  1. New pyridazinone-4-carboxamides as new cannabinoid receptor type-2 inverse agonists: Synthesis, pharmacological data and molecular docking

    European Journal of Medicinal Chemistry, Vol. 127, pp. 398-412

  2. Overexpression of the cytokine BAFF and autoimmunity risk

    New England Journal of Medicine, Vol. 376, Núm. 17, pp. 1615-1626

  3. Uso atual e aceitabilidade de novos testes diagnósticos para tuberculose ativa: Um inquérito mundial

    Jornal Brasileiro de Pneumologia, Vol. 43, Núm. 5, pp. 380-392

2016

  1. Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study

    The Lancet Infectious Diseases, Vol. 16, Núm. 12, pp. 1364-1376

  2. Tricyclic pyrazoles. Part 8. Synthesis, biological evaluation and modelling of tricyclic pyrazole carboxamides as potential CB2receptor ligands with antagonist/inverse agonist properties

    European Journal of Medicinal Chemistry, Vol. 112, pp. 66-80

2015

  1. Synthesis, pharmacological evaluation and docking studies of pyrrole structure-based CB2 receptor antagonists

    European Journal of Medicinal Chemistry, Vol. 101, pp. 651-667

  2. Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: The International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program

    Journal of Viral Hepatitis, Vol. 22, Núm. 5, pp. 469-480

2012

  1. Genome-wide association study of multiple sclerosis confirms a novel locus at 5p13.1

    PLoS ONE, Vol. 7, Núm. 5

2007

  1. Effects of progestagens on follicular growth and oocyte developmental competence in FSH-treated ewes

    Domestic Animal Endocrinology, Vol. 32, Núm. 4, pp. 303-314